Clinical trial for efficacy of HT048 consumption with MNT on body composition and blood lipid level

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0001290

Enrollment

105

Registered

2014-12-01

Start date

2014-05-12

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The participants enrolled in this study was assigned to 3 groups by double-blinde randomization

Product HT048-01 group: HT048 400mg/cap *3 times/day, 12weeks Product HT048-02 group: TH048 280 mg/cap * 3 times/day, 12weeks Placebo group: placebo *3 times/day, 12weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Body mass index between 25 and 30 kg/m2 The person who voluntarily agree to participate on this study

Exclusion criteria

Exclusion criteria: 1)systolic blood pressure =160 mmHg and diastolic pressure =100 mmHg, or hypertensive person who take diuretics 2) fastig glucose =126 mg/dl or random blood sugar tes =200 mg/dl, or diabetes who take oral hypoglycemic agent or insulin therapy 3) who have heart, kidney, thyroid, and cerebrovascular disease 4) who have polycystic syndrom, gastrointestinal disease, gout,porphyria 5) who have psychological problems such as depression, schizophrenia, alcoholism, and drug addiction 6) who take agent for obesity treatment(lipid absorption inhibitors, anti-depressants, appetite suppresants, contraceptive, steroids, hormons) 7) pregnant or breast feeding 8) who have participated on obesity program or taken dietary supplemnt in 30 days prior to study 9) considered to be not able to engage in active exercise with severe skeletal problems 10)who had diagnosed or treated with cancer within 5 years 11) who had asthma and other allergy 12) who were alcoholic or adictive 13) who participated other clinical trial within 3 months prior to this study 14) who have history of surgery within 6 months 15) who are limited to read 16) who are not considrered to be appropriate to particiapt on this study

Design outcomes

Primary

Measure	Time frame
Area of viceral fat on abdomen and hip-thigh	—

Secondary

Measure	Time frame
Anthropometry;blood chemistry analysis;dietary analysis	—

Countries

Korea, Republic of

Contacts

Public ContactBo Hyung Kim

Kyung Hee University

Outcome results